.png){kind=icon}
.png){kind=icon}
Return
DNA-origami-engineered NAC-linkers enable the construction of humanized liver organoids for modeling ischemia-reperfusion injury
.png){kind=icon}
OA
AI
DOI：10.1016/j.asems.2026.100180.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Hepatic ischemia-reperfusion injury (IRI) is a major cause of liver dysfunction and failure following surgical procedures such as liver resection and transplantation. Although numerous studies have reported various underlying mechanisms involving both parenchymal and nonparenchymal cells, there is an urgent need to develop human-relevant models that faithfully recapitulate clinical IRI. To address this, we established a novel threedimensional liver organoid model using NAC linker technology to simulate hepatic IRI in both murine and human contexts. By coculturing primary hepatocytes with nonparenchymal cells (NPCs) and immune components such as peripheral blood mononuclear cells (PBMCs) or THP-1 monocytes, we developed multicellular organoids that recapitulate key structural and functional features of the liver. We demonstrated that oxidative stress induced by H 2 O 2 triggers inflammatory and apoptotic responses consistent with IRI, which are exacerbated by immune cell involvement. Furthermore, we identified the YAP signaling pathway as a critical protective mechanism: its activation attenuated cellular damage and inflammation, whereas its inhibition worsened injury. These findings highlight the utility of NAC-liver organoids as a robust platform for studying IRI mechanisms and screening therapeutic agents, with YAP agonists emerging as promising candidates for mitigating IRI-related damage.
Keywords:
Ischemia-reperfusion injury
NAC-Linker
Liver organoid
Yes-associated protein
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
10.2
Papers:
17
Citations:
0
View more organizations